Legionella longbeachae
Legionella longbeachae is a gram-negative, flagellated, aerobic bacterium from the genus Legionella. It is one of the causative agents of Legionnaires' disease, a severe form of pneumonia. The bacterium was first isolated in 1980 from a patient in Long Beach, California, hence its name.
Characteristics[edit]
Legionella longbeachae is a rod-shaped bacterium that is motile due to its flagella. It is a facultative anaerobe, meaning it can grow in both oxygen-rich and oxygen-poor environments. The bacterium is also catalase and oxidase positive.
Pathogenesis[edit]
Legionella longbeachae is primarily found in soil and composted plant material, unlike other Legionella species which are typically associated with aquatic environments. Humans can become infected by inhaling dust contaminated with the bacteria. Once in the lungs, the bacteria invade and replicate within alveolar macrophages, leading to pneumonia.
Clinical Manifestations[edit]
The clinical manifestations of Legionella longbeachae infection are similar to those of other forms of Legionnaires' disease. Symptoms include fever, chills, cough, and shortness of breath. In severe cases, the infection can lead to respiratory failure and death.
Diagnosis and Treatment[edit]
Diagnosis of Legionella longbeachae infection is typically made by culture of respiratory secretions, urine antigen testing, or PCR. Treatment usually involves antibiotics such as macrolides or quinolones.
Prevention[edit]
Prevention of Legionella longbeachae infection involves avoiding exposure to dust from soil and compost, particularly for individuals with weakened immune systems or chronic lung disease.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian